A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)
Clinical trial NCT07086079 · COMPLETED
Trial details
- NCT number
- NCT07086079
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-26
- Primary completion
- 2025-12-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.